XTalks

MARCH 18, 2024

The precision fermentation study highlights how genetically engineered microorganisms can inhibit the growth of foodborne pathogens. The study proposes a new system for categorizing genetically engineered products to improve public perception and acceptance.

Genetic Engineering 52

Genetic Engineering Genetics Production Protein 52

FDA Law Blog

DECEMBER 8, 2022

labeling of major food allergens in bulk foods, dietary supplements, protein-free ingredients, and foods produced through genetic engineering); and. labeling of major food allergens in bulk foods, dietary supplements, protein-free ingredients, and foods produced through genetic engineering); and. Other technical labeling matters.

Genetic Engineering 59

Genetic Engineering Containment Cosmetics Protein 59

Scienmag

SEPTEMBER 16, 2020

Research from the Texas A&M College of Engineering could lead to new approaches to treating viruses and cancers Credit: Dr. Wonmuk Hwang, Texas A&M University College of Engineering Research led by Dr. Wonmuk Hwang has led to better understanding on how components of the body’s immune system find intruding or damaged cells, which could (..)

Engineer 52

Engineer Research Allergies Medicine 52

Scienmag

JUNE 14, 2021

Investments have catalyzed research, clinical trials and revolutionary treatments across many disciplines UC San Francisco is launching a new initiative to propel the development of living therapeutics – a category of treatments broadly defined as human and microbial living cells that are selected, modified, or engineered to treat or cure disease (..)

Development 75

Development Engineer Clinical Trials Clinical Trials 75

Scienmag

DECEMBER 10, 2020

Rebecca DuBois, associate professor of biomolecular engineering at UC Santa […].

Antibody 98

Antibody Engineer Development Research 98

XTalks

SEPTEMBER 21, 2023

This groundbreaking endeavor has received support from the National Institute of Allergy and Infectious Diseases (NIAID). These T cells are engineered to recognize various HIV proteins in a unique manner compared to previous experimental HIV vaccines.

Vaccination 59

Vaccination Vaccine Trials Clinical Trials 59

Scienmag

APRIL 14, 2021

In mouse models of psoriasis, the nanofiber-based drug […].

Engineer 64

Engineer Development Drugs Allergies 64

pharmaphorum

FEBRUARY 9, 2021

It is sponsored by the US-government funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. AZ went on to engineer the antibodies to have a longer half-life in the body with its proprietary technology.

Antibody 52

Antibody Trials Allergies Engineer 52

Scienmag

APRIL 29, 2021

Now, in two related papers published April 28, 2021 in Science Translational Medicine, researchers at UCSF have demonstrated how to engineer […].

Clinical Trials 46

Clinical Trials Clinical Trials Engineer Trials 46

The Pharma Data

AUGUST 24, 2020

This requires an 11-day programme which involves extracting blood from an HIV patient and separating their T cells, which are then engineered in a lab to make them immune to HIV. In a paper published in Molecular Therapy: Methods & Clinical Development , the team discussed why they choose this type of gene therapy to treat HIV.

Gene Therapy 52

Gene Therapy Gene FDA Approval Trials 52

Scienmag

OCTOBER 27, 2020

Now, researchers at the Pritzker School of Molecular Engineering (PME) at the University of Chicago […]. But just how immune cell receptors work together to sense multiple molecules and make these decisions remained a mystery.

Bacteria 46

Bacteria Vaccination Vaccine Engineer 46

Scienmag

FEBRUARY 1, 2021

Houston Methodist and MD Anderson researchers collaborated on study in Nature Biomedical Engineering HOUSTON-(Feb.

Development 42

Development Engineer Drugs Research 42

Scienmag

MARCH 24, 2021

Researchers at the Pritzker School of Molecular Engineering at the […]. But many cancer immunotherapy treatments can be expensive, have devastating side effects, and only work in a fraction of patients.

Engineer 40

Engineer Research Allergies Vaccination 40

Drug Discovery World

JANUARY 21, 2024

Accelerating biotherapeutics development through technology platforms Anubhav Tripathi is a Professor of Medical Science and Engineering at Brown University. At Brown, Tripathi’s research group develops biotechnology platforms by integrating biological and engineering principles.

Protein 52

Protein Vaccination Vaccine Development 52

XTalks

NOVEMBER 30, 2023

Engineered to instruct the immune system to generate T cells capable of recognizing HIV and triggering an immune response to thwart the establishment of chronic infection, VIR-1388 represents a promising avenue in HIV prevention. In addition, Vir Biotechnology, Inc.

FDA Approval 111

FDA Approval Gene Therapy Clinical Trials Clinical Trials 111

Scienmag

FEBRUARY 2, 2021

” Their process enabled them to engineer two new, drug-like compounds that […].

Scientist 40

Scientist Engineer Drugs Research 40

Trialfacts

NOVEMBER 26, 2023

relating to cancer, tuberculosis, human immunodeficiency virus infection and acquired immune deficiency syndrome, or any genetic muscle diseases or disorders) Must not have hypersensitivity or known allergy to any medications Must be able to attend study visits at the research site over approximately 14 weeks (without interference of vacations etc.)

Research 52

Research Protein Insulin Allergies 52

Delveinsight

AUGUST 27, 2020

The phase 1 study that is being run by the National Institute of Allergy and Infectious Diseases tests three dose levels of the vaccine, mRNA-1273, given in two injections a month apart in 120 adults. Moderna showed robust phase 1 results for its COVID-19 vaccine in adults up to 55 last month.

Vaccination 53

Vaccination Vaccine Research Trials 53

Drug Discovery World

NOVEMBER 9, 2023

Ahead of protein and antibody engineering conference PEGS Europe 2024 in Lisbon, DDW’s Megan Thomas looks at what to expect from each track of the annual biologics technology meeting. Croasdale-Wood will then participate in a keynote chat, interviewed by Miho.

Engineer 52

Engineer Antibody Protein In-Vivo 52

Drug Discovery World

DECEMBER 19, 2022

From human B cells to engineered antibodies, IgGenix is taking a novel approach towards breaking through the last frontier of immunology: allergies.

Antibody 52

Antibody Allergies Genome Genomics 52

Drug Discovery World

NOVEMBER 15, 2022

From human B cells to engineered antibodies, IgGenix is taking a novel approach towards breaking through the last frontier of immunology: allergies.

Antibody 52

Antibody Allergies Genome Genomics 52

Drug Discovery World

DECEMBER 6, 2022

From human B cells to engineered antibodies, IgGenix is taking a novel approach towards breaking through the last frontier of immunology: allergies.

Antibody 52

Antibody Allergies Genome Genomics 52

Drug Discovery World

NOVEMBER 29, 2022

From human B cells to engineered antibodies, IgGenix is taking a novel approach towards breaking through the last frontier of immunology: allergies.

Antibody 52

Antibody Allergies Genome Genomics 52

Scienmag

AUGUST 5, 2020

Announces exclusive licensing partnerships for proprietary regulatory T cell engineering technologies with Seattle Children’s Research Institute, Benaroya Research Institute and MIGAL Galilee Research Institute Credit: GentiBio, Inc. BOSTON, Mass., SEATTLE, Wash., and QIRYAT SHMONA, Israel, August 5, 2020 – GentiBio, Inc.,

Engineer 52

Engineer Development Licensing Licensing 52

Drug Discovery World

NOVEMBER 23, 2022

From human B cells to engineered antibodies, IgGenix is taking a novel approach towards breaking through the last frontier of immunology: allergies.

Antibody 52

Antibody Allergies Genome Genomics 52

Drug Discovery World

NOVEMBER 16, 2022

From human B cells to engineered antibodies, IgGenix is taking a novel approach towards breaking through the last frontier of immunology: allergies.

Antibody 52

Antibody Allergies Genome Genomics 52

The Pharma Data

DECEMBER 17, 2020

An Fc-engineered monoclonal antibody targeting the HER2 oncoprotein, MARGENZA offers hope for patients who have received two or more prior anti-HER2 regimens, with at least one being for metastatic disease. When Pigs Fly Allergy-friendly. Importantly, a consistent safety profile was maintained.

FDA Approval 52

FDA Approval Genome Genomics Production 52

The Pharma Data

FEBRUARY 22, 2021

Working with experts using an AI-powered platform that engineers food proteins, Bayer is supporting science to help the hundreds of millions of people around the world who suffer from food allergies or sensitivities, including gluten. Improving diets through increased quality and access.

Gene Editing 40

Gene Editing Genome Genomics Protein 40

Bioengineer

JULY 15, 2021

In rankings recently released by the National Science Foundation, Pitt ranked fifth among all American universities in total federal science and engineering research and development support.

Medicine 52

Medicine Clinical Trials Clinical Trials Scientist 52

Drug Discovery World

FEBRUARY 3, 2023

One of these candidates is VSV-SUDV, developed and tested by scientists at NIH’s National Institute of Allergy and Infectious Diseases in Hamilton, Montana. No treatment or vaccine for SUDV disease is licensed, although candidates are in clinical and preclinical trials.

Vaccination 52

Vaccination Vaccine Genetic Engineering Protein 52

Roots Analysis

MARCH 16, 2023

The IVT mRNAs are structurally similar to natural mRNAs, these synthetic mRNAs can be used to express proteins through genetic engineering. In the last few years, researchers have become interested in using in vitro transcribed (IVT) mRNA as a drug delivery agent.

Vaccination 52

Vaccination Vaccine DNA Protein 52

Scienmag

APRIL 26, 2021

Susan Landau’s ‘People Count’ Credit: The MIT PRESS, 2021. How do you stop a pandemic before a vaccine arrives? Contact tracing is key, the first step in a process that has proven effective: trace, test, and isolate.

Vaccination 77

Vaccination Vaccine Allergies Engineer 77

Scienmag

JANUARY 4, 2021

In advance of public vaccination, a quick and accurate COVID-19 antibody test will help determine the presence of neutralizing antibodies, the molecules that aid in protection against the virus. Credit: UAB BIRMINGHAM, Ala.

Vaccination 98

Vaccination Vaccine Antibody Development 98

Scienmag

APRIL 22, 2021

Research sets the stage for biotech to generate 1 billion doses in less than a month Credit: Justin Muir By cracking open a cellular membrane, Northwestern University synthetic biologists have discovered a new way to increase production yields of protein-based vaccines by five-fold, significantly broadening access to potentially lifesaving medicines. (..)

Production 84

Production Vaccination Vaccine Protein 84

Scienmag

NOVEMBER 17, 2020

Lysyl oxidase plays several important roles in promoting fibrosis in patients with scleroderma and is a potential biomarker of treatment response Credit: Sarah Pack, Medical University of South Carolina A team of researchers at the Medical University of South Carolina (MUSC) has found that the molecule lysyl oxidase (LOX) plays a number of important (..)

Research 83

Research Allergies Engineer Development 83

Scienmag

JULY 12, 2021

Research highlights the critical role of the immune system in the aging process Researchers from the Buck Institute and Stanford University have created an inflammatory clock of aging (iAge) which measures inflammatory load and predicts multi-morbidity, frailty, immune health, cardiovascular aging and is also associated with exceptional longevity in (..)

Research 75

Research Bioinformatics Allergies Engineer 75

Scienmag

DECEMBER 22, 2020

Around a third of the world’s population carries Toxoplasma gondii, a parasite that puts people with a weakened immune system at risk and can trigger malformations in the womb. The single-celled pathogen also leads to economic losses in agriculture, with toxoplasmosis increasing the risk of abortion among sheep, for example.

Genetic Engineering 40

Genetic Engineering Engineer Genetics Allergies 40